TD Cowen and H.C. Wainwright have raised price targets on KalVista Pharmaceuticals, expressing confidence in its oral hereditary angioedema treatment ahead of the company's fourth-quarter financial results.
Clinical-stage biotech Erasca (ERAS) has seen its stock skyrocket over the past 12 months, hitting a multi-year high. While technical momentum is strong, the company remains pre-revenue, with its fate tied to future drug approvals, presenting a classic high-risk, high-reward scenario for investors.
As Palantir Technologies prepares to report Q4 results, soaring demand for its AI platform collides with sky-high valuations, leaving investors to weigh robust growth against bubble fears.
WK Kellogg Co. names former Ferrero executive Jean-Baptiste Santoul as Chief Operating Officer, signaling a strategic shift following its $3.1 billion acquisition by the global confectionery giant.
New clinical imaging data for Molecular Partners' experimental radiotherapeutic MP0712, targeting the DLL3 protein in cancers like small cell lung cancer, show favorable tumor targeting and healthy organ clearance. The company confirms its U.S. Phase I/II trial is now open for patient screening.
Fifth Third Bancorp has finalized its $12.3 billion acquisition of Comerica Bank, with customer system conversions and branch rebranding scheduled to begin after Labor Day. The deal reshapes Michigan's banking landscape and creates the nation's ninth-largest bank.
CNBC's Jim Cramer expressed renewed bullishness on Tesla, shifting focus from its electric vehicle business to its ambitions in robotics and autonomous 'Cybercab' technology following the company's latest earnings call.
CNBC's Jim Cramer tempered enthusiasm for Novo Nordisk stock, suggesting investors hold rather than buy after its massive gains driven by blockbuster weight-loss drugs.
Amazon's latest round of layoffs will eliminate over 2,200 corporate positions in the Seattle region, part of a broader 16,000-person global workforce reduction. The cuts, effective from late April, add to a wave of job losses hitting Washington's tech sector.
The rapid adoption of algorithmic decision-making in UK banks has created a critical lag in oversight and accountability structures, leaving institutions exposed to risks that traditional governance models are ill-equipped to manage.
Goldman Sachs' investment arm leads a major funding round in Fieldguide, an AI platform for auditors and accountants, signaling a strategic push into the automation of professional services and a potential new growth vector for the Wall Street giant.
As BHP Group advances plans to create one of the world's first fully autonomous copper mines at Escondida Norte, it simultaneously contends with Chinese import restrictions on its Jimblebar iron ore and ramps up exploration via its 2026 Xplor program, highlighting the complex balancing act facing the global mining giant.
Amid subscription fatigue and market fragmentation, the proposed union of Netflix and Warner Bros. Discovery is framed not as a threat to competition, but as a necessary consolidation to compete with tech giants and refocus value on consumers.
The payments giant reported a 15% jump in revenue, beating Wall Street estimates, as it positions itself to capitalize on emerging trends in stablecoins and AI-driven commerce.
Sources indicate Disney's board is finalizing plans to appoint theme parks chairman Josh D’Amaro as the company's next chief executive, concluding a lengthy succession search. The move would place the profitable parks division veteran at the helm of the global entertainment giant.
Fifth Third Bancorp has finalized its $12.3 billion acquisition of Comerica Bank, with customer system conversions and branch rebranding to begin in September. The deal creates the ninth-largest U.S. bank and significantly expands Michigan's branch network, though some closures and layoffs are expected.
Newly unsealed correspondence contradicts CEO's prior statements, sparking investor concern amid broader challenges for the electric vehicle maker.
The latest partial government shutdown has forced a delay in the highly anticipated January employment data, marking a recurring disruption to the nation's economic indicators and leaving markets and policymakers in the dark.
German federal prosecutors have arrested five individuals accused of operating a sophisticated smuggling network that allegedly funneled millions of euros worth of dual-use goods to Russian defense firms, in violation of EU sanctions imposed after the invasion of Ukraine.
IDEAYA Biosciences shares have retreated from recent highs, sparking debate among investors. While a discounted cash flow model suggests deep undervaluation, price-to-sales metrics paint a contrasting picture of a premium stock. We examine the numbers behind the volatility and what it signals for the precision oncology company's future.
